Covid-19 will usher in a new era where work from home is an increasing part of people’s regular schedule.

As microbes become resistant to treatments, the international community must pool its resources and expertise and create a not-for-profit taskforce to develop new drugs and prevent catastrophe, says Tadataka Yamada